The Wall Street Journal: Zenefits slashes valuation in half to avoid investor lawsuits

Embattled health-benefits broker Zenefits on Thursday said it struck a deal with some investors to cut its valuation by more than half to $2 billion, giving them additional shares in exchange for releasing the company of potential legal claims.